NYT Business
US · 3 hrs ago
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
Do you trust NYT Business?
Sign in to rate
Discussion
?
No comments yet — be the first to start the discussion!